- Home
- IAC vs TVTX Comparison
IAC vs TVTX Comparison
Compare IAC & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IAC
- TVTX
- Stock Information
- Founded
- IAC N/A
- TVTX 2008
- Country
- IAC United States
- TVTX United States
- Employees
- IAC N/A
- TVTX N/A
- Industry
- IAC Computer Software: Programming Data Processing
- TVTX Biotechnology: Pharmaceutical Preparations
- Sector
- IAC Technology
- TVTX Health Care
- Exchange
- IAC Nasdaq
- TVTX Nasdaq
- Market Cap
- IAC 2.7B
- TVTX 3.1B
- IPO Year
- IAC 1992
- TVTX N/A
- Fundamental
- Price
- IAC $34.30
- TVTX $35.69
- Analyst Decision
- IAC Buy
- TVTX Strong Buy
- Analyst Count
- IAC 12
- TVTX 15
- Target Price
- IAC $48.67
- TVTX $37.21
- AVG Volume (30 Days)
- IAC 1.5M
- TVTX 2.1M
- Earning Date
- IAC 11-03-2025
- TVTX 10-30-2025
- Dividend Yield
- IAC N/A
- TVTX N/A
- EPS Growth
- IAC N/A
- TVTX N/A
- EPS
- IAC N/A
- TVTX N/A
- Revenue
- IAC $3,653,760,000.00
- TVTX $435,826,000.00
- Revenue This Year
- IAC N/A
- TVTX $108.68
- Revenue Next Year
- IAC $0.08
- TVTX $40.23
- P/E Ratio
- IAC N/A
- TVTX N/A
- Revenue Growth
- IAC 23.49
- TVTX 114.22
- 52 Week Low
- IAC $29.56
- TVTX $12.91
- 52 Week High
- IAC $50.49
- TVTX $36.87
- Technical
- Relative Strength Index (RSI)
- IAC 57.80
- TVTX 63.19
- Support Level
- IAC $31.42
- TVTX $34.18
- Resistance Level
- IAC $34.43
- TVTX $36.87
- Average True Range (ATR)
- IAC 1.01
- TVTX 1.88
- MACD
- IAC 0.11
- TVTX -0.24
- Stochastic Oscillator
- IAC 92.48
- TVTX 78.15
About IAC IAC Inc.
IAC Inc is comprised of businesses including Angi Inc, Dotdash Meredith and Care.com, among many others ranging from early stage to established businesses. Its Dotdash Meredith segment consists of its Digital and Print businesses. Angi segment offers repairing and remodeling homes to cleaning and landscaping services. Care.com segment is a online destination for families to connect with caregivers for their children, aging parents, pets and homes and for caregivers to connect with families seeking care services. Search segment consists of a collection of websites providing general search services and information, and a Desktop business, which includes business-to-business partnership operations.
About TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.